Home » Topics » BioWorld Science

BioWorld Science
RSS

Spero awarded funding to develop SPR-994

July 17, 2018

Longevity Biotech launches clinical neuroinflammation biomarker study

July 17, 2018

Pfizer begins pivotal phase III program for fidanacogene elaparvovec in hemophilia B

July 17, 2018

CAPSTONE-2 influenza trial of baloxavir marboxil meets primary objective

July 17, 2018

Destiny Pharma and Aston University establish biofilm research collaboration

July 17, 2018

Researchers present clinical data for RG-7916 in patients with SMA

July 17, 2018

Phase III CREDENCE trial of Invokana stopped early due to promising outcomes

July 17, 2018

RegenxBio initiates first-in-human trial of RGX-111 for treatment of MPS I

July 17, 2018

Neurotrope initiates enrollment in confirmatory phase II study of bryostatin-1

July 17, 2018

Promising data presented from completed pivotal study of PRO-140 with HAART for HIV-1

July 17, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...